Target intelligence / Profile preview

p53 response element (p53RE) (p53RE)

Target
p53RE
Molecular classification
DNA regulatory element, Transcription factor binding site, Cis-regulatory element
01

Overview

The p53 response element (p53RE) is a specific genomic DNA sequence that serves as the primary binding site for the p53 tumor suppressor protein, often referred to as the guardian of the genome (Vogelstein et al., 2000, Nature). These elements typically follow a consensus motif consisting of two decameric half-sites (5-RRRCWWGYYY-3) separated by a spacer of 0 to 13 base pairs (Riley et al., 2008, Nat Rev Mol Cell Biol). When p53 binds to these sites, it functions as a sequence-specific transcription factor, recruiting co-activators to initiate the expression of downstream target genes such as CDKN1A (p21), BAX, and MDM2. This transcriptional program is essential for mediating cellular responses to stress, including DNA repair, cell cycle arrest, and apoptosis. In the context of oncology, many p53 mutations disrupt the protein's ability to recognize or bind to these DNA sites, thereby abrogating its tumor-suppressive capacity. Therapeutic interventions, such as APR-246 (Eprenetapopt) and Nutlins, aim to restore or enhance p53 binding to these response elements to reactivate the apoptotic pathway in malignant cells (Bykov et al., 2018, Nat Rev Cancer). Consequently, the p53RE represents the critical regulatory node where p53-mediated signaling is translated into biological outcomes.

Other names
p53 binding sitep53-binding elementp53-responsive elementp53REp53 response element DNA
02

Mechanism of action

Restoration of p53 transcriptional activity by promoting the folding of mutant p53 or preventing the MDM2-mediated degradation of wild-type p53, thereby facilitating sequence-specific binding to DNA response elements.

03

Biological functions

ApoptosisCell cycle arrestDNA repairSenescenceMetabolic regulationAngiogenesis inhibition
04

Disease associations

CancerLi-Fraumeni syndrome
05

Safety considerations

Systemic toxicity due to p53-mediated apoptosis in healthy tissuesThrombocytopeniaGastrointestinal toxicityPotential for selecting p53-deficient clonesOff-target transcriptional activation
06

Interacting drugs

APR-246 (Eprenetapopt)

5 more in the full profile.

07

Biomarkers

p21 (CDKN1A) mRNA/protein levelsMDM2 expressionBAX expressionPUMA expressionp53 mutation status

Beyond the preview

Go deeper on p53 response element (p53RE) (p53RE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on p53 response element (p53RE) (p53RE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call